Latest Property Portfolio News

Growthpoint Properties Australia kicks off FY26 with robust leasing activity, high occupancy rates, and a strategic $24 million industrial acquisition, maintaining its financial guidance and sustainability credentials.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

Goodman Group reports robust progress in Q1 FY26 with a $12.4 billion development pipeline dominated by data centres, reaffirming a 9% operating EPS growth forecast. The group is advancing logistics automation and expanding data centre capacity across key global markets.

Opthea has significantly reduced its operating costs and settled a key financial liability, positioning itself for a strategic review aimed at unlocking shareholder value.

CAQ Holdings reported a 7% drop in leasing revenue amid persistently high vacancy rates and cash flow pressures in the September 2025 quarter. The company is negotiating lease renewals and seeking debt facility extensions to sustain operations.

Charter Hall Retail REIT has acquired four Bunnings net lease hardware assets for $151 million, enhancing its convenience retail portfolio and raising its FY26 earnings and distribution forecasts.

Dotz Nano has secured its first commercial order for its advanced carbon capture sorbent and raised A$1.2 million to accelerate development of its DotzEarth technology, marking a pivotal step towards commercialization in the growing DAC market.

Peter Warren Automotive reports a strong FY25 with underlying profit before tax of $22.3 million, driven by disciplined inventory and cost management. The company declares a 4 cent fully franked dividend and signals confidence in growth through innovation and acquisitions.

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.

EVT Limited reports a robust 20.7% rise in Q1 EBITDA, driven by all divisions, with Hotels leading record results and a strategic acquisition poised to boost earnings further.

BrainChip Holdings has moved its AKD1500 neuromorphic AI chip into volume production, supported by key supply agreements and expanded distribution channels, while maintaining a stable cash position.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.